Αναζήτηση | Sngine-YND

σε πρόσθεσε στο άλλο

2025-12-23 06:35:01

Global Dasatinib Drugs Market Strategic Analysis

The Global Dasatinib Drugs Market Size Was Valued at USD 1.36 Billion in 2023 and is Projected to Reach USD 2.5 Billion by 2032, Growing at a CAGR of 6.98% From 2024-2032. Dasatinib is a potent, second-generation tyrosine kinase inhibitor (TKI) primarily utilized in the treatment of specific types of blood cancers, most notably Philadelphia chromosome-positive ($Ph+$) Chronic Myeloid Leukemia...

0 Σχόλια 0 Μοιράστηκε 85 Views